Advent Life Sciences Fund III LP is a venture capital fund based in London, United Kingdom. According to its most recent Form D, filed Dec 6, 2019, it has sold $24,800,000 of interests to 3 investors since its first sale in Dec 2018. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Als III GP LLP; Kaasim Mahmood; Rajesh Parekh.
- Total raised
- $24,800,000Cumulative sales reported on Form D
- Investors
- 3
- First sale
- Dec 12, 2018
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Als III GP LLP; Kaasim Mahmood; Rajesh Parekh
- Latest Form D
- Dec 6, 2019
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Advent Life Sciences Fund III LP
What is the minimum investment for Advent Life Sciences Fund III LP?
Advent Life Sciences Fund III LP's latest Form D, filed Dec 6, 2019, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Advent Life Sciences Fund III LP?
Advent Life Sciences Fund III LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Advent Life Sciences Fund III LP raised?
Advent Life Sciences Fund III LP reports $24,800,000 sold from 3 investors on its Form D filed Dec 6, 2019. This is cumulative sales since the offering began, not current assets or performance.
Where is Advent Life Sciences Fund III LP based?
Advent Life Sciences Fund III LP is based in London, United Kingdom.
When did Advent Life Sciences Fund III LP launch?
Advent Life Sciences Fund III LP reports its first sale in Dec 2018.
Size compared with every venture capital fund
Raised more than 63% of the 41 venture capital funds based in United Kingdom, and more than 93% of all 14,865 that report sales.